(1R,4R)-6'-FLUORO-(N-METHYLE- OU N,N-DIMETHYLE-)-4-PHENYLE-4',9'-DIHYDRO-3'H-SPIRO-[CYCLOHEXANE-1,1'-PYRANO[3,4,B]INDOL]-4-AMINE UTILISE DANS LE TRAITEMENT DE LA FIBROMYALGIE ET DU SYNDROME DE LA FATIGUE CHRONIQUE
The invention relates to a pharmaceutical dosage form comprising (1r,4r)-6'-Fluoro-(N- methyl- or N,N-dimethyl-)-4-phenyl-4',9'-dihydro-3'H-spiro-[cyclohexane-1,1'-pyrano[3,4,b]- indol]-4-amine or a physiologically acceptable salt thereof, for use in the treatment of fibromyalgia or chronic fatigue syndrome.